PDLI SG&A Expense Growth
Pdl Biopharma Inc · SG&A Expense Growth
PDLI SG&A Expense Growth
Latest reported-13.55%period ending
PDLI FY SG&A Growth (YoY) (0.00% → -13.55%)
Latest values, visible window
High-resolution chart · PNG
PDLI sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -13.5536% | |
| -1.2081% | |
| 57.0224% | |
| 11.7429% | |
| 3.3683% | |
| 17.3383% | |
| 16.8283% | |
| 57.654% | |
| -87.9347% | |
| 535.6627% | |
| -59.1339% | |
| -23.4878% | |
| -44.2585% | |
| 46.6948% | |
| 159.0266% | |
| 15.1849% | |
| 44.6237% | |
| 21.4104% | |
| 29.8596% | |
| 23.5714% | |
| 12.6437% | |
| 31.8182% | |
| 17.8571% | |
| 0% |